PAX3 and alveolar rhabdomyosarcoma: In order to test whether the altered TGF-β-response in ARMS cells is due to the presence of PAX3-FOXO1, we challenged these cells with TGF-β after the siRNA-mediated inhibition of PAX3-FOXO1.